Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy

Key facts

Sponsor

Bausch & Lomb Incorporated

Principal Investigator

Carlos Pavesio, MD, MD

Medical Retina Service/Moorfields Eye Hospital

Intervention

fluocinolone acetonide intravitreal implant(drug)

Enrollment

140 enrolled

Eligibility

6 years · All sexes

Timeline

2002 – 2006

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.